Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Martin Griesshammer, Parvis Sadjadian & Kai Wille. (2018) Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy. Expert Review of Hematology 11:9, pages 697-706.
Read now
Read now
Francesco Passamonti & Mario Lazzarino. (2003) Treatment of Polycythemia Vera and Essential Thrombocythemia: The Role of Pipobroman. Leukemia & Lymphoma 44:9, pages 1483-1488.
Read now
Read now
Apostolia-Maria Tsimberidou & Francis J. Giles. (2002) Essential Thrombocythemia (ET): Moving from Palliation to Cure. Hematology 7:6, pages 315-323.
Read now
Read now
Tiziano Barbui, Guido Finazzi & Thomas C. Pearson. (1997) The Management of Essential Thrombocythaemia. Hematology 2:2, pages 91-100.
Read now
Read now
Articles from other publishers (44)
Emanuela Sant'Antonio, Oscar Borsani, Chiara Camerini, Cirino Botta, Marco Santoro, Alessandro Allegra & Sergio Siragusa. (2022) Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy. Blood Reviews 52, pages 100903.
Crossref
Crossref
Jane Esther Dahlstrom, Akila Subramaniam & Ona Marie Faye-Petersen. 2022. Benirschke's Pathology of the Human Placenta. Benirschke's Pathology of the Human Placenta
507
554
.
P. Merviel, J. Hannigsberg, C. Tremouilhac, S. Herrmann, A.H. Saliou, P.F. Dupré, C. De Moreuil, E. Pasquier, E. Le Moigne & F. Couturaud. (2021) Abortos espontáneos recurrentes. EMC - Ginecología-Obstetricia 57:3, pages 1-17.
Crossref
Crossref
Kate Burbury & Ashish Panigrahi. (2021) Esssential thrombocythaemia and pregnancy—A need for prospective study and a consensus on its management. Leukemia Research 102, pages 106500.
Crossref
Crossref
Sung-Yong Kim, Sung Hwa Bae, Soo-Mee Bang, Ki-Seong Eom, Junshik Hong, Seongsoo Jang, Chul Won Jung, Hee-Jin Kim, Ho Young Kim, Min Kyoung Kim, Soo-Jeong Kim, Yeung-Chul Mun, Seung-Hyun Nam, Jinny Park, Jong-Ho Won & Chul Won Choi. (2021) The 2020 revision of the guidelines for the management of myeloproliferative neoplasms. The Korean Journal of Internal Medicine 36:1, pages 45-62.
Crossref
Crossref
Susan E. Robinson & Claire N. Harrison. (2020) How we manage Philadelphia‐negative myeloproliferative neoplasms in pregnancy. British Journal of Haematology 189:4, pages 625-634.
Crossref
Crossref
Mohammad Abu-Tineh, Nancy Kassem, Mohammad Abdul-Jaber Abdulla, Omar Mohammad Ismail, Rola Ghasoub, Mahmood B. Aldapt & Mohamed A. Yassin. (2020) Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar. Case Reports in Oncology 13:1, pages 336-340.
Crossref
Crossref
Ivy Altomare & Craig M. Kessler. 2019. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
346
373
.
Yoko Edahiro, Jun Ando, Toshifumi Suzuki, Yuki Fukumura, Azuchi Masuda, Shiori Sakayori, Jun Takeda, Yojiro Maruyama, Shintaro Makino, Atsuo Itakura & Norio Komatsu. (2018) Multiple Placental Infarcts in a Pregnant Woman with Essential Thrombocythemia. Internal Medicine 57:24, pages 3647-3650.
Crossref
Crossref
Mathieu Puyade, Emilie Cayssials, Fabrice Pierre & Olivier Pourrat. (2017) Pregnancy and myeloproliferative neoplasms : A retrospective monocentric cohort. Obstetric Medicine 10:4, pages 165-169.
Crossref
Crossref
Mihaela Maria Ghinea, Zizi Niculescu, C. Niculescu & M. Grigorian. (2016) Essential thrombocythemia – Incidence of thrombotic complications. ARS Medica Tomitana 22:2.
Crossref
Crossref
Chul Won Choi, Soo-Mee Bang, Seongsoo Jang, Chul Won Jung, Hee-Jin Kim, Ho Young Kim, Soo-Jeong Kim, Yeo-Kyeoung Kim, Jinny Park & Jong-Ho Won. (2015) Guidelines for the management of myeloproliferative neoplasms. The Korean Journal of Internal Medicine 30:6, pages 771-788.
Crossref
Crossref
Noa Lavi, Benjamin Brenner & Irit Avivi. (2013) Management of pregnant women with myeloproliferative neoplasms. Thrombosis Research 131, pages S11-S13.
Crossref
Crossref
P. Yazdani Brojeni, I. Matok, F. Garcia Bournissen & G. Koren. (2012) A systematic review of the fetal safety of interferon alpha. Reproductive Toxicology 33:3, pages 265-268.
Crossref
Crossref
Marie-Cécile Valera, Olivier Parant, Christophe Vayssiere, Jean-François Arnal & Bernard Payrastre. (2011) Essential thrombocythemia and pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 158:2, pages 141-147.
Crossref
Crossref
Martin Griesshammer, Sabine Struve & Tiziano Barbui. (2008) Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy. Blood Reviews 22:5, pages 235-245.
Crossref
Crossref
Jean B Brière. (2007) Essential thrombocythemia. Orphanet Journal of Rare Diseases 2:1.
Crossref
Crossref
Toshiko Iwashita, Mayumi Fujitani, Yoshiaki Yamamoto, Tatsuya Katsurada & Yataro Yoshida. (2006) Interferon-alfa Treatment of Essential Thrombocythemia during Pregnancy. Internal Medicine 45:20, pages 1161-1164.
Crossref
Crossref
Melinda Fritz, Kalyani Vats & Rakesh K Goyal. (2005) Neonatal Lupus and IUGR Following Alpha-Interferon Therapy during Pregnancy. Journal of Perinatology 25:8, pages 552-554.
Crossref
Crossref
Claire Harrison. (2005) Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. British Journal of Haematology 129:3, pages 293-306.
Crossref
Crossref
Riitta Niittyvuopio, Eeva Juvonen, Risto Kaaja, Kalevi Oksanen, Heikki Hallman, Timo Timonen & Tapani Ruutu. (2004) Pregnancy in essential thrombocythaemia: experience with 40 pregnancies. European Journal of Haematology 73:6, pages 431-436.
Crossref
Crossref
Alessandro M. Vannucchi, Alberto Grossi, Alessandro Pancrazzi, Elisabetta Antonioli, Paola Guglielmelli, Francesca Balestri, Monica Biscardi, Simona Bulgarelli, Giovanni Longo, Claudio Graziano, Luigi Gugliotta & Alberto Bosi. (2004)
PRV-1
, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia
. British Journal of Haematology 127:2, pages 214-219.
Crossref
Crossref
Thomas P. Duffy. 2004. Medical Complications During Pregnancy. Medical Complications During Pregnancy
69
86
.
Michelle A Elliott & Ayalew Tefferi. (2003) Thrombocythaemia and pregnancy. Best Practice & Research Clinical Haematology 16:2, pages 227-242.
Crossref
Crossref
Monica Galli & Tiziano Barbui. (2003) Antiphospholipid antibodies and pregnancy. Best Practice & Research Clinical Haematology 16:2, pages 211-225.
Crossref
Crossref
Claire N. Harrison . (2002) Current trends in essential thrombocythaemia. British Journal of Haematology 117:4, pages 796-808.
Crossref
Crossref
D.M.O. Becroft, J.M.D. Thompson & E.A. Mitchell. (2002) The Epidemiology of Placental Infarction at Term. Placenta 23:4, pages 343-351.
Crossref
Crossref
Tiziano Barbui. (2002) What is the standard treatment in essential thrombocythemia. International Journal of Hematology 76:S2, pages 311-317.
Crossref
Crossref
Abdalla M. Fayyad, David R. Brummitt, Helen F. Barker & Stephen F. Spooner. (2003) May–Hegglin anomaly: the role of aspirin in the treatment of this rare platelet disorder in pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology 109:2, pages 223-224.
Crossref
Crossref
Anne Greist. (2008) The Role of Blood Component Removal in Essential and Reactive Thrombocytosis. Therapeutic Apheresis 6:1, pages 36-44.
Crossref
Crossref
A. Tefferi & S. Murphy. (2001) Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management. Blood Reviews 15:3, pages 121-131.
Crossref
Crossref
C Thauvin-Robinet, C Maingueneau, E Robert, E Elefant, H Guy, D Caillot, RO Casasnovas, S Douvier & A Nivelon-Chevallier. (2001) Exposure to hydroxyurea during pregnancy: a case series. Leukemia 15:8, pages 1309-1311.
Crossref
Crossref
Curtis A. Wright & Ayalew Tefferi. (2001) A single institutional experience with 43 pregnancies in essential thrombocythemia. European Journal of Haematology 66:3, pages 152-159.
Crossref
Crossref
Ayalew Tefferi, Rafael Fonseca, Denise L. Pereira & H. Clark Hoagland. (2001) A Long-term Retrospective Study of Young Women With Essential Thrombocythemia. Mayo Clinic Proceedings 76:1, pages 22-28.
Crossref
Crossref
T. Yee Khong. 2001. Fetal and Neonatal Pathology. Fetal and Neonatal Pathology
93
110
.
Ayalew Tefferi, Lawrence A SolbergJr.Jr. & Murray N Silverstein. (2000) A clinical update in polycythemia vera and essential thrombocythemia. The American Journal of Medicine 109:2, pages 141-149.
Crossref
Crossref
Pier Mannuccio Mannucci. (2000) Few platelets, many platelets: the role of the internist. European Journal of Internal Medicine 11:1, pages 4-8.
Crossref
Crossref
Mitsuhiro Hiratsuka, Hisanori Minakami, Shiro Koshizuka & Ikuo Sato. (2000) Administration of interferon-? during pregnancy: effects on fetus. Journal of Perinatal Medicine 28:5.
Crossref
Crossref
Martin Griesshammer, Lothar Bergmann & Tom Pearson. (1998) 9 Fertility, pregnancy and the management of myeloproliferative disorders. Baillière's Clinical Haematology 11:4, pages 859-874.
Crossref
Crossref
Ayalew Tefferi & Murray N. Silverstein. (1998) 4 Treatment of polycythaemia vera and essential thrombocythaemia. Bailli?re's Clinical Haematology 11:4, pages 769-785.
Crossref
Crossref
S. Willoughby & T.C. Pearson. (1998) The use of aspirin in polycythaemia vera and primary thrombocythaemia. Blood Reviews 12:1, pages 12-22.
Crossref
Crossref
Jan Jacques Michiels. (2009) Essential thrombocythaemia is not associated with postpartum thrombosis or an increased risk of venous thromboembolism. European Journal of Haematology 60:2, pages 138-139.
Crossref
Crossref
Ayalew Tefferi. (1998) Pregnancy and thrombocythemia. American Journal of Hematology 57:2, pages 181-182.
Crossref
Crossref
S. J. B. Willoughby, T. C. Pearson, S. Fairhead & B. E. Woodcock. (2009) Postpartum thrombosis in primary thrombocythaemia. European Journal of Haematology 59:2, pages 121-123.
Crossref
Crossref